Synonyms: R-411 | RO-0272441
Compound class:
Synthetic organic
Comment: Valategrast (RO-0272441) is an orally available, small molecule α4 integrin inhibitor that was developed by Roche [2]. It is active at α4β1 and α4β7 integrins.
|
|
No information available. |
Summary of Clinical Use ![]() |
Valategrast was advanced to phase 1 clinical evaluation in healthy volunteers [1]. As of mid-March 2021 there were no studies registered with ClinicalTrials.gov. |